Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Pressmeddelande 16 juni 2020 Immunicum AB (publ) meddelar att resultaten från fas I/II-studien med Ilixadencel vid gastrointestinala stromacellstumörer (GIST) publicerats i Cancer Immunology,...
-
Press Release 16 June 2020 Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Gastrointestinal Stromal Tumors (GIST) in Cancer...
-
Pressmeddelande 15 juni 2020 Immunicum AB (publ) meddelar övergång till fortlöpande inklusionsfas i Fas Ib/II kombinationsstudien ILIAD Immunicum AB (publ; IMMU.ST) meddelade i dag att den sjätte...
-
Press Release 15 June 2020 Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial Immunicum AB (publ; IMMU.ST) announced today...
-
Pressmeddelande 13 maj 2020 Immunicum AB (publ) meddelar att Peter Hein har utsetts till tillförordnad finanschef Immunicum AB (publ) meddelar idag att Peter Hein har utsetts till tillförordnad...
-
Press Release 13 May 2020 Immunicum AB (publ) Announces Appointment of Peter Hein as Interim Chief Financial Officer Immunicum AB (publ; IMMU.ST) announced today that Peter Hein has been appointed...
-
Pressmeddelande 6 maj 2020 Immunicum AB (publ) erhåller Regenerative Medicine Advanced Therapy Designation från FDA för Ilixadencel i njurcancer Immunicum AB (publ; IMMU.ST) meddelar idag att...
-
Press Release 6 May 2020 Immunicum AB (publ) Receives Regenerative Medicine Advanced Therapy Designation from FDA for Ilixadencel in Kidney Cancer Immunicum AB (publ; IMMU.ST) announced today...
-
Pressmeddelande 28 april 2020 Kommuniké från årsstämma i Immunicum AB (publ) den 28 april 2020 Vid årsstämma i Immunicum AB (publ), org. nr 556629-1786, (”Bolaget”) den 28 april 2020 fattades bland...
-
Press Release 28 April 2020 Report from the Annual General Meeting of Immunicum AB (publ) on April 28, 2020 At the Annual General Meeting (the “AGM”) of Immunicum AB (publ), reg. no 556629-1786,...